| View |
|
DRP-15326
|
Thiamine Hydrochloride (Vit. B1) + Pyridoxine Hydrochloride (Vit. B6) + Cyanocobalamin
(Vit. B12)
|
None
|
100 mg/ 5 mg/ 50 mcg
|
Tablet
|
Vitamins
|
Pascual Laboratories, Inc.
|
Philippines
|
Initial
|
20 June 2024
|
20 June 2026
|
| View |
|
DRHR-2368
|
Ethyl Alcohol
|
None
|
70 mL/100 mL (70% v/v)
|
Solution
|
Antiseptic / Disinfectant
|
Dann's Aid Lab. Inc.
|
Philippines
|
Initial
|
19 June 2024
|
19 June 2029
|
| View |
|
DRHR-2369
|
Isopropyl Alcohol
|
Adamson
|
70 mL / 100 mL (70% v/v)
|
Solution
|
Antiseptic / Disinfectant
|
Jovash International, Inc.
|
Philippines
|
Initial
|
19 June 2024
|
19 June 2029
|
| View |
|
DRP-15335
|
Telmisartan + Amlodipine (as besilate)
|
Duocard
|
80 mg/ 10 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB) and Calcium
Channel Blocker
|
Ravian Life Science Pvt. Ltd.
|
India
|
Initial
|
24 June 2024
|
24 June 2029
|
| View |
|
DRP-15336
|
Telmisartan + Amlodipine Besilate
|
Duocard
|
40 mg/ 5 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB) and Calcium
Channel Blocker
|
Ravian Life Science Pvt. Ltd.
|
India
|
Initial
|
24 June 2024
|
24 June 2029
|
| View |
|
DRP-15328
|
Amikacin (as sulfate)
|
Amiksan 50
|
50 mg/mL (100 mg/2ml)
|
Solution for Injection
(IM/IV)
|
Antibacterial (Aminoglycoside)
|
Sanjar Pharma LLP
|
India
|
Initial
|
21 June 2024
|
21 June 2029
|
| View |
|
DRP-15330
|
Amikacin (as sulfate)
|
Amiksan 250
|
250mg/mL (500mg/2ml)
|
Solution for Injection (IM/IV)
|
Antibacterial (Aminoglycoside)
|
Sanjar Pharma LLP
|
India
|
Initial
|
21 June 2024
|
21 June 2029
|
| View |
|
DRP-15329
|
Amikacin (as sulfate)
|
Amiksan 125
|
125mg/mL (250mg/2ml)
|
Solution for Injection
(IM/IV)
|
Antibacterial (Aminoglycoside)
|
Sanjar Pharma LLP
|
India
|
Initial
|
21 June 2024
|
21 June 2029
|
| View |
|
DRP-15275
|
Esomeprazole (as sodium)
|
Esomax-IV
|
40 mg
|
Lyophilized Powder for Injection (IV)
|
Proton Pump Inhibitor
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
04 June 2024
|
04 June 2029
|
| View |
|
DRP-15298
|
Vancomycin Hydrochloride
|
Vanoxo-500
|
500 mg
|
Powder for Injection (I.V.)
|
Antibacterial
|
Indasi Lifescience Pvt. Ltd.
|
India
|
Initial
|
13 June 2024
|
13 June 2029
|
| View |
|
DRP-15297
|
Vancomycin (as hydrochloride)
|
Vanoxo-1000
|
1g
|
Powder for Injection (I.V.)
|
Antibacterial
|
Indasi Lifescience Pvt. Ltd.
|
India
|
Initial
|
13 June 2024
|
13 June 2029
|
| View |
|
DRP-15334
|
Methimazole
|
None
|
20mg
|
Tablet
|
Anti-Thyroid Drug
|
Novagen Healthcare Private Limited
|
India
|
Initial
|
21 June 2024
|
21 June 2026
|
| View |
|
DRP-15338
|
Diosmin Hesperidin.
|
Dioslife-500
|
450 mg/50 mg
|
Film-coated Tablet
|
Vasoprotective (Capillary Stabilizing Agent)
|
Flourish Pharma
|
India
|
Initial [OTC]
|
25 June 2024
|
25 June 2029
|
| View |
|
DRP-15339
|
Diosmin + Hesperidin
|
Dioslife-1000
|
900 mg/100 mg
|
Film-coated Tablet
|
Vasoprotective (Capillary Stabilizing Agent)
|
Flourish Pharma
|
India
|
Initial [OTC]
|
25 June 2024
|
25 June 2029
|
| View |
|
DRP-15337
|
Iron Folic Acid (Vitamin B9)
|
Fefolife
|
300 mg/250 mg
|
Film-coated Tablet
|
Mineral/Vitamin
|
Flourish Pharma
|
India
|
Initial [OTC]
|
25 June 2024
|
25 June 2029
|
| View |
|
DRP-12333-03
|
Diosmin+Hesperidin
|
Gospiridin
|
900 mg/100 mg
|
Tablet
|
Vasoprotective
|
Saga Lifesciences Limited
|
India
|
CLIDP Conversion
|
10 June 2024
|
20 July 2027
|
| View |
|
DRP-12528-04
|
Celecoxib
|
Novabrex 200
|
200 mg
|
Capsule
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Ratnatris Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 June 2024
|
26 August 2027
|
| View |
|
DRP-12544-05
|
Azithromycin (as dihydrate)
|
Maxithro
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
AMN Life Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 June 2024
|
31 August 2027
|
| View |
|
DRP-12561-09
|
Metformin Hydrochloride
|
Metter
|
|
500 mg
|
Oral hypoglycemic Agent (Biguanide)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
11 June 2024
|
02 September 2027
|
| View |
|
DRP-12591-04
|
Cefixime (as trihydrate)
|
Curexime
|
100 mg/ 5 mL (20 mg/mL)
|
Powder for Oral Suspension
|
Antibacterial (Cephalosporin)
|
Globela Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 June 2024
|
19 September 2027
|